TrialBreast cancer research : BCR2017

Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.

Masakazu Toi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.